Heterogenous antibody and T-cell responses to SARS-CoV-2 mRNA vaccines among immunocompromised young people

Clin Transl Med. 2023 Jan;13(1):e1183. doi: 10.1002/ctm2.1183.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibodies
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2* / genetics
  • T-Lymphocytes

Substances

  • COVID-19 Vaccines
  • Antibodies